CTTACC 2023

This is the fifth in a series of conferences entitled “Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Medicine” It is our belief that cellular therapies, adjuncts in resuscitation and novel blood products represent critical areas in transfusion medicine that have the potential to dramatically improve outcomes in trauma patients. Previous conferences have resulted in multiple cross-disciplinary collaborations and grants for pre-clinical studies and clinical trials.

Our mission is highly focused on supporting the development and translation of novel therapies in trauma and critical care medicine. The goal of our meeting is to bring together the expertise and input of blood bankers, cell therapy producers, clinicians, basic scientists, industry, FDA, NIH, AABB, DARPA, BARDA and DOD representatives to discuss current research and existing barriers in the translation of these novel therapies in trauma and critical care medicine, a field with limited therapeutic options and unlimited opportunities for advancement.